Close Menu

NEW YORK – Invitae reported after the close of the market Wednesday that its fourth quarter 2019 revenues increased 47 percent from the prior year.

For the three months ended Dec. 31, 2019, Invitae reported $66.3 million in revenues compared to $45.4 million in Q4 2018, falling short of the consensus Wall Street estimate of $68.1 million. Invitae reported testing revenue of $65.1 million for the quarter, as well as $1.2 million in other revenue.

Invitae accessioned around 148,000 samples in Q4 2019 compared to more than 87,000 samples in Q4 2018.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.

Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.

A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.

In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.